DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Sampson HA, Leung DYM, Burks AW. et al
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
J Allergy Clin Immunol 2011;
127 (05) 1309-1310.e1
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.